Skip to content

Improving Patient and Family Centered Care in Advanced Critical Illness

Improving Patient and Family Centered Care in Advanced Critical Illness

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01844492
Acronym
PARTNER
Enrollment
1420
Registered
2013-05-01
Start date
2012-07-23
Completion date
2016-02-18
Last updated
2018-03-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, Depression

Keywords

decision making for incapacitated patients, intensive care, surrogate decision making, patient centered care, Palliative Care, End of Life, Quality of Communication

Brief summary

One in five deaths in the U.S. occurs in or shortly after discharge from an intensive care unit (ICU), typically following decisions made by surrogate decision makers to forego life prolonging treatment. A large body of empirical research has identified deficiencies in care processes that contribute to three important problems: 1) family members often experience poor quality communication with ICU clinicians, leading to lasting psychological distress associated with the ICU experience; 2) patients near the end of life frequently receive invasive, expensive treatment that is inconsistent with their values and preferences, and 3) end-of-life care is a major contributor to health care costs.\[8, 9\] Although advance care planning can prevent some unwanted treatment, many patients wish for a trial of intensive treatment when the prognosis is uncertain, and therefore it seems likely that the need for interventions to improve in-the-moment decisions by surrogates will persist.\[10, 11\] In a pilot project, the investigators developed the PARTNER intervention (PAiring Re-engineered ICU Teams with Nurse-driven Emotional Support and Relationship-building), an interdisciplinary intervention that 1) gives new responsibilities and advanced communication skills training to existing ICU staff (local nurse leaders and social work members of the ICU team); 2) changes care defaults to ensure frequent clinician-family meetings; and 3) adds protocolized, nurse-administered coaching and emotional support of surrogates before and during clinician-family meetings. The objective of this proposal is to conduct a stepped wedge randomized controlled trial testing the PARTNER intervention in 5 ICUs among 1000 patients with advanced critical illness and their surrogates.

Interventions

BEHAVIORALThe PARTNER Intervention

The PARTNER intervention (PAiring Re-engineered ICU Teams with Nurse-driven Emotional Support and Relationship-building) consists of: 1) institution of a clinical pathway for family support overseen by ICU staff nurses; 2) advanced communication skills training for ICU staff nurses; 3) a multifaceted strategy to support implementation of the clinical pathway for family support.

OTHERICU Usual Care Control

The control group will receive usual care, in which the frequency and content of clinician-family communication is determined by the clinical team according to their usual practice. No study ICU has a protocolized approach to family communication and instead clinicians determine the timing and frequency of communication with families. All sites have palliative care services.

Sponsors

University of Pittsburgh
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Intervention model description

Sample size listed is for patients (n=1420), for whom 809 surrogates completed long-term follow-up

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* 18 years of age or older * Surrogate decision maker for ICU patient in one of 5 UPMC ICU's

Exclusion criteria

* Non-English Speaking * Surrogate's loved one is for organ transplantation * Not physically able to participate in family meeting

Design outcomes

Primary

MeasureTime frameDescription
Hospital Anxiety and Depression ScaleAt 6 monthsSymptom burden of anxiety and depression in family members in a telephone interview 6 months after enrollment using the validated 14-item Hospital Anxiety and Depression scale (HADS).

Secondary

MeasureTime frameDescription
Patient-and Family Centeredness of Care ScaleAt 6 monthsPatient and Family -Centeredness of Care, using the 12-item Patient-Perceived Patient-Centeredness of Care Scale (PPPC) adapted for use by surrogates.
Quality of Communication (QOC) scaleAt 6 monthsQuality of communication in family members in a telephone interview 6 months after enrollment using the validated19 item Quality of Communication Scale.
Intensive Care Unit Length of StayParticipants will be followed for duration of ICU stay, an expected average of 21 days.Intensive Care Unit length of stay as assessed by abstraction of this information from hospital administrative records.
Total Hospitalization costsDuration of hospital stay, an expected average of 4 weeksTotal hospitalization costs by aggregating each patient's total service specific costs, generated from hospital administrative records. We will stratify this analysis by the patient's vital status at hospital discharge.
Impact of Events Scale of Care ScaleAt 6 monthsWe will assess symptoms of post-traumatic stress in family members in a telephone interview 6 months after enrollment using the validated 22 item Impact of Events Scale.

Other

MeasureTime frameDescription
Hospital Length of StayParticipants will be followed for duration of hosptial stay, an expected average of 4 weeks.We will assess hospital length of stay.
6-month health care utilizationinclusive of index hospitalization and 6 months follow upWe will assess patient health care utilization using hospital records and through standardized interviews with surrogates at 6 months.
Katz Activities of Daily Living ScaleAt 6 monthsFunctional status of the patient using the validated Katz Activities of Daily Living Scale at 6 months.
MortalityAt 6 monthsHospital mortality and 6-month mortality using hospital administrative records, and the 6-month follow-up with surrogates.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 24, 2026